ATE203665T1 - Stabilisierte pharmazeutische zusammensetzungen und verfahren zu ihrer herstellung - Google Patents
Stabilisierte pharmazeutische zusammensetzungen und verfahren zu ihrer herstellungInfo
- Publication number
- ATE203665T1 ATE203665T1 AT97951339T AT97951339T ATE203665T1 AT E203665 T1 ATE203665 T1 AT E203665T1 AT 97951339 T AT97951339 T AT 97951339T AT 97951339 T AT97951339 T AT 97951339T AT E203665 T1 ATE203665 T1 AT E203665T1
- Authority
- AT
- Austria
- Prior art keywords
- pharmaceutical compositions
- production
- methods
- stabilized pharmaceutical
- stabilized
- Prior art date
Links
- 239000008194 pharmaceutical composition Substances 0.000 title abstract 2
- 108010061435 Enalapril Proteins 0.000 abstract 1
- OFOBLEOULBTSOW-UHFFFAOYSA-N Propanedioic acid Natural products OC(=O)CC(O)=O OFOBLEOULBTSOW-UHFFFAOYSA-N 0.000 abstract 1
- 229960000309 enalapril maleate Drugs 0.000 abstract 1
- OYFJQPXVCSSHAI-QFPUQLAESA-N enalapril maleate Chemical group OC(=O)\C=C/C(O)=O.C([C@@H](C(=O)OCC)N[C@@H](C)C(=O)N1[C@@H](CCC1)C(O)=O)CC1=CC=CC=C1 OYFJQPXVCSSHAI-QFPUQLAESA-N 0.000 abstract 1
- VZCYOOQTPOCHFL-UPHRSURJSA-N maleic acid Chemical compound OC(=O)\C=C/C(O)=O VZCYOOQTPOCHFL-UPHRSURJSA-N 0.000 abstract 1
- 239000011976 maleic acid Substances 0.000 abstract 1
- VZCYOOQTPOCHFL-UHFFFAOYSA-N trans-butenedioic acid Natural products OC(=O)C=CC(O)=O VZCYOOQTPOCHFL-UHFFFAOYSA-N 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
- A61K38/05—Dipeptides
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/55—Protease inhibitors
- A61K38/556—Angiotensin converting enzyme inhibitors
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
- A61K47/12—Carboxylic acids; Salts or anhydrides thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2004—Excipients; Inactive ingredients
- A61K9/2013—Organic compounds, e.g. phospholipids, fats
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- General Health & Medical Sciences (AREA)
- Epidemiology (AREA)
- Engineering & Computer Science (AREA)
- Immunology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Gastroenterology & Hepatology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Molecular Biology (AREA)
- Vascular Medicine (AREA)
- Biophysics (AREA)
- General Chemical & Material Sciences (AREA)
- Oil, Petroleum & Natural Gas (AREA)
- Medicinal Preparation (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Materials For Medical Uses (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| HU9603489A HU222497B1 (hu) | 1996-12-18 | 1996-12-18 | Enalapril-maleátot tartalmazó stabilizált gyógyszerkészítmény és eljárás előállítására |
| PCT/HU1997/000084 WO1998026765A1 (en) | 1996-12-18 | 1997-12-15 | Stabilized pharmaceutical compositions and process for the preparation thereof |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| ATE203665T1 true ATE203665T1 (de) | 2001-08-15 |
Family
ID=89994561
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| AT97951339T ATE203665T1 (de) | 1996-12-18 | 1997-12-15 | Stabilisierte pharmazeutische zusammensetzungen und verfahren zu ihrer herstellung |
Country Status (8)
| Country | Link |
|---|---|
| EP (1) | EP0952823B1 (de) |
| AT (1) | ATE203665T1 (de) |
| AU (1) | AU5493298A (de) |
| DE (1) | DE69705967T2 (de) |
| ES (1) | ES2160978T3 (de) |
| HU (1) | HU222497B1 (de) |
| PT (1) | PT952823E (de) |
| WO (1) | WO1998026765A1 (de) |
Families Citing this family (12)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US6296871B1 (en) | 1998-04-12 | 2001-10-02 | Ranbaxy Laboratories Limited | Stable solid pharmaceutical compositions containing enalapril maleate |
| MY121470A (en) * | 1999-05-03 | 2006-01-28 | Ranbaxy Lab Ltd | Stable solid pharmaceutical compositions containing enalapril maleate |
| WO2001019348A1 (en) * | 1999-09-17 | 2001-03-22 | Mylan Pharmaceuticals Inc. | Stabilization of enalapril maleate with maleic acid |
| AT5874U1 (de) * | 2000-12-29 | 2003-01-27 | Bioorg Bv | Pharmazeutische zubereitungen enthaltend amlodipinmaleat |
| RU2207869C1 (ru) * | 2002-04-04 | 2003-07-10 | Акционерное Курганское общество медицинских препаратов и изделий "Синтез" | Фармацевтическая твердая композиция на основе эналаприла малеата и способ ее получения |
| WO2012085249A2 (en) | 2010-12-24 | 2012-06-28 | Krka, D.D., Novo Mesto | Homogenous pharmaceutical oral dosage forms comprising lercanidipine and enalapril or their pharmaceutically acceptable salts |
| CN102357084B (zh) * | 2011-10-11 | 2014-02-26 | 广东彼迪药业有限公司 | 一种马来酸依那普利的片剂组合物及其制备与应用 |
| EP2765855A4 (de) * | 2011-10-12 | 2015-03-25 | Merck Sharp & Dohme | Pharmazeutische zusammensetzungen zur disproportionierungshemmung |
| RS66600B1 (sr) | 2014-07-31 | 2025-04-30 | Pharmathen Sa | Mini-tablete koje su disperzibilne u vodi koje sadrže enalapril maleat za lečenje hipertenzije u pedijatrijskoj populaciji i postupak za njihovo dobijanje |
| CN107007838B (zh) * | 2016-09-30 | 2021-07-20 | 南京优科制药有限公司 | 一种含有马来酸依那普利、叶酸和酸稳定剂的药物组合物 |
| CN106963938B (zh) * | 2016-09-30 | 2021-04-30 | 南京优科制药有限公司 | 一种马来酸依那普利叶酸的药物组合物及其制备方法 |
| CN117205165A (zh) * | 2023-10-12 | 2023-12-12 | 安徽爱宠生物科技有限公司 | 宠物用马来酸依那普利片处方工艺开发 |
Family Cites Families (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4793998A (en) * | 1986-10-20 | 1988-12-27 | Warner-Lambert Company | Stabilized drug compositions |
| HU222489B1 (hu) * | 1990-07-25 | 2003-07-28 | Novartis Ag. | Stabilizált gyógyszerkészítmények és eljárás az előállításukra |
-
1996
- 1996-12-18 HU HU9603489A patent/HU222497B1/hu not_active IP Right Cessation
-
1997
- 1997-12-15 EP EP97951339A patent/EP0952823B1/de not_active Expired - Lifetime
- 1997-12-15 WO PCT/HU1997/000084 patent/WO1998026765A1/en not_active Ceased
- 1997-12-15 PT PT97951339T patent/PT952823E/pt unknown
- 1997-12-15 ES ES97951339T patent/ES2160978T3/es not_active Expired - Lifetime
- 1997-12-15 DE DE69705967T patent/DE69705967T2/de not_active Expired - Lifetime
- 1997-12-15 AU AU54932/98A patent/AU5493298A/en not_active Abandoned
- 1997-12-15 AT AT97951339T patent/ATE203665T1/de not_active IP Right Cessation
Also Published As
| Publication number | Publication date |
|---|---|
| HU9603489D0 (en) | 1997-02-28 |
| AU5493298A (en) | 1998-07-15 |
| DE69705967T2 (de) | 2002-04-04 |
| WO1998026765A1 (en) | 1998-06-25 |
| EP0952823B1 (de) | 2001-08-01 |
| ES2160978T3 (es) | 2001-11-16 |
| DE69705967D1 (de) | 2001-09-06 |
| HUP9603489A2 (hu) | 1998-08-28 |
| PT952823E (pt) | 2001-12-28 |
| HU222497B1 (hu) | 2003-07-28 |
| HUP9603489A3 (en) | 1998-12-28 |
| EP0952823A1 (de) | 1999-11-03 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| DE59610280D1 (de) | Neue aminosäurederivate, verfahren zu ihrer herstellung und diese verbindungen enthaltende pharmazeutische zusammensetzungen | |
| DE69902535D1 (de) | Phenoxypropanolamin-derivate, verfahren zu ihrer herstellung und diese enthaltenden pharmazeutischen zusammensetzungen | |
| TR200200785T2 (tr) | 8-Fenil-6,9-dihidro-[1,2,4] triazolo [3,4-i] purin-5-on türevleri | |
| IL115790A0 (en) | Pharmaceutical compositions containing boronic ester and acid compounds and methods for the preparation thereof | |
| DE69921941D1 (de) | Verfahren zur Herstellung von pharmazeutischen Wirkstoffpartikeln | |
| ATE296823T1 (de) | Substituierte heterocyclische verbindungen, verfahren zu ihrer herstellung und diese verbindungen enthaltende pharmazeutische zusammensetzungen | |
| ATE252562T1 (de) | Pyrazolcarbonsäurederivate, verfahren zu ihrer herstellung und diese enthaltende pharmazeutische zusammensetzungen | |
| WO2001044272A3 (en) | Daptomycin analogs as antibacterial agents | |
| DK0758248T3 (da) | Formuleringer til faktor IX | |
| WO2001044271A3 (en) | Daptomycin analogs and their use as antibacterial agents | |
| DK0747050T3 (da) | Farmaceutiske sammensætninger indeholdende irbesartan | |
| EP1089968A4 (de) | Thyroidhormon-analoga und verfahren zu ihrer herstellung | |
| ATA195788A (de) | Tripeptide, verfahren zu ihrer herstellung und diese enthaltende pharmazeutische zusammensetzungen | |
| TR199801861T2 (xx) | Farmas�tik olarak yararl� bile�imler. | |
| ATE219069T1 (de) | Neue arylglycinamidderivate, verfahren zu ihrer herstellung und diese verbindungen enthaltende pharmazeutische zusammensetzungen | |
| ATE203665T1 (de) | Stabilisierte pharmazeutische zusammensetzungen und verfahren zu ihrer herstellung | |
| ATE430160T1 (de) | Lipopeptid-stereoisomere, verfahren zu ihrer herstellung und nützliche zwischenprodukte | |
| DE19983660T1 (de) | Verfahren zur Aufreinigung von Lösungsmitteln, die bei der Herstellung von pharmazeutischen Zusammensetzungen nützlich sind | |
| IL129616A0 (en) | Novel CIS-3,4-chroman derivatives useful in the prevention or treatment of estrogen related diseases or syndromes | |
| TR200000291T2 (tr) | Taşikinin reseptör antagonistleri olarak 2-asilaminopropanaminler. | |
| AU6415994A (en) | Substituted caprolactams and derivatives thereof useful for treatment of hiv disease | |
| DE69104220D1 (de) | Verfahren zur Herstellung von direktkomprimierten, Cephalosporansäure Derivate enthaltendenTabletten. | |
| DE69812164D1 (de) | Lösemittelfreies verfahren zur herstellung von terpolymeren von maleinsäureanhydrid, c1-c4-alkyl vinylether und isobutylen mit hohem molekulargewicht und zahnprothesehaftmittel und zahnpasten die diese terpolymere enthalten | |
| DE69638049D1 (de) | Neue n-benzyldioxol-imidazolderivate, verfahren zu ihrer herstellung, erhaltene zwischenprodukte, pharmazeutische zusammensetzungen und ihre verwendung als endothelin-antagonisten | |
| IL129627A0 (en) | Novel CIS-3,4-chroman derivatives useful in the prevention or treatment of estrogen related diseases or syndromes |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| RER | Ceased as to paragraph 5 lit. 3 law introducing patent treaties |